Minimally invasive versus open primary liver resections for hepatocellular carcinoma

Hu, Qiang; Sun, Yuanshui; Zhu, Kai

doi:10.1002/jso.26592

Cited by 3 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, whether indocyanine green fluorescence-guided laparoscopic hepatectomy (ICG-guided LH) or liver resection have an advantage in survival rate remains unclear. Previous studies have suggested less blood loss, less intraoperative blood transfusion rate, shorter operation time, shorter hospital stay and lower complication rate during surgery with ICG fluorescence navigation (5,6,(10)(11)(12)(13)(14). These studies mostly involved only a few cases and lacked propensity score matching (PSM) and prognostic data (15).…”

Section: Introductionmentioning

confidence: 99%

“…In the past ten years, the application of laparoscopic hepatectomy (LH) has been popular all over the world ( 4 ), especially in large expert centers. In contrast to open hepatectomy, LH seems to have similar oncological survival outcomes, shorter hospital stay, less blood loss and less operative morbidity ( 5 , 6 ). To better judge the boundary of the tumor and the extent of resection during laparoscopic surgery, indocyanine green (ICG) fluorescence navigation has been applied during laparoscopy.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Indocyanine green fluorescence-guided laparoscopic hepatectomy versus conventional laparoscopic hepatectomy for hepatocellular carcinoma: A single-center propensity score matching study

et al. 2022

View full text Add to dashboard Cite

BackgroundIndocyanine green fluorescence-guided laparoscopic hepatectomy (ICG-guided LH) is increasingly used for the treatment of hepatocellular carcinoma (HCC). However, whether ICG-guided LH can improve surgical outcomes remains unclear. This study aimed to investigate the short-term outcomes and survival outcomes of ICG-guided LH versus common laparoscopic hepatectomy (CLH) for HCC.MethodsWe conducted a retrospective analysis of 104 ICG-guided LH and 158 CLH patients from 2014 to 2020 at our center. To avoid selection bias, 81 ICG-guided LH and 81 CLH cases were analyzed after 1:1 propensity score matching (PSM). The baseline data and results were compared between the two groups.ResultsThe baseline characteristics of both groups were comparable after matching. There was a significant difference in operative time: longer in the ICG-guided LH group than in the CLH group (p=0.004). However, there was no significant difference in operative time in anatomical resection between the two groups (p=0.987). There was a significant difference in operative time in non-anatomical resection: longer in the ICG-guided LH group than in the CLH group (p=0.001). There were no significant differences in positive surgery margin, blood loss, blood transfusion rate, postoperative complication rate, postoperative length of hospital stay, mortality within 30 days, and mortality within 90 days. The ICG-guided LH group appeared to have a trend towards better overall survival (OS), but there was no significant difference in OS (P=0.168) and recurrence-free survival (RFS) (P=0.322) between the two groups.ConclusionsAlthough ICG fluorescence-guided LH is a timelier procedure to perform, it is a safe and effective technique with the advantages of intraoperative positioning, low postoperative complication rates, and potential to improve OS.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Indocyanine green fluorescence-guided laparoscopic hepatectomy versus conventional laparoscopic hepatectomy for hepatocellular carcinoma: A single-center propensity score matching study

et al. 2022

View full text Add to dashboard Cite

show abstract

Reply: Comparison between short and long‐term outcomes after minimally‐invasive versus open primary liver resections for hepatocellular carcinoma

Goh

2021

Journal of Surgical Oncology

View full text Add to dashboard Cite

Development and validation of a postoperative pulmonary infection prediction model for patients with primary hepatic carcinoma

Lu,

Xing,

Xia

et al. 2023

World J Gastrointest Oncol

View full text Add to dashboard Cite

Esophageal cancer (EC) is one of the most common digestive system malignancies in the world. The combined modality treatment of EC is usually surgery and radiation therapy, however, its clinical efficacy for advanced patients is relatively limited. Ferroptosis, a new type of iron-dependent programmed cell death, is different from apoptosis, necrosis and autophagy. In recent years, many studies have further enlightened that ferroptosis plays an essential role in the occurrence, development and metastasis of tumors. Targeting ferroptosis stimulates a new direction for further exploration of oncologic treatment regimens. Furthermore, ferroptosis has a critical role in the immune microenvironment of tumors. This paper reviews the mechanism of ferroptosis and the ferroptosis research progress in the treatment of EC. We further elaborate the interaction between ferroptosis and immunotherapy, and the related mechanisms of ferroptosis participation in the immunotherapy of EC, so as to provide new directions and ideas for the treatment of EC.

show abstract

Minimally invasive versus open primary liver resections for hepatocellular carcinoma

Cited by 3 publications

References 9 publications

Indocyanine green fluorescence-guided laparoscopic hepatectomy versus conventional laparoscopic hepatectomy for hepatocellular carcinoma: A single-center propensity score matching study

Indocyanine green fluorescence-guided laparoscopic hepatectomy versus conventional laparoscopic hepatectomy for hepatocellular carcinoma: A single-center propensity score matching study

Reply: Comparison between short and long‐term outcomes after minimally‐invasive versus open primary liver resections for hepatocellular carcinoma

Development and validation of a postoperative pulmonary infection prediction model for patients with primary hepatic carcinoma

Contact Info

Product

Resources

About